Russell Frank Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Russell Frank Company’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,942	Closed	-$335K	–	3179
2015 Q1	$335K	Sell	1,942 -7,904	-80%	-$1.16M	﹤0.01%	2513
2014 Q4	$1.11M	Sell	9,846 -7,183	-42%	-$870K	﹤0.01%	2088
2014 Q3	$2.66M	Buy	17,029 +2,606	+18%	+$378K	﹤0.01%	1618
2014 Q2	$1.91M	Buy	14,423 +9,698	+205%	+$1.07M	﹤0.01%	1777
2014 Q1	$488K	Sell	4,725 -5,306	-53%	-$543K	﹤0.01%	2394
2013 Q4	$977K	Sell	10,031 -5,917	-37%	-$472K	﹤0.01%	2085
2013 Q3	$1.07M	Sell	15,948 -37,173	-70%	-$2.56M	﹤0.01%	2143
2013 Q2	$3.51M	Buy	+53,121	New	+$3.04M	0.01%	1456

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Russell Frank Company's SLXP Position: Q2 2015 in Review

Russell Frank Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,942 shares — an estimated $335K sold.

Russell Frank Company first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $3.51M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Russell Frank Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Russell Frank Company sold 1,942 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $335K.
Russell Frank Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Russell Frank Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.51M in Q2 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.